See also this year's filing and all EDGAR filings for this company.
PDF Report 0001443863_2021_Biocorrx_Inc.pdf
Logs
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Assets', 'missing_ratio': 0.14340874483358712, 'aggregate_val': 819975, 'exp_sum': 717132, 'exp_to_value': {'IntangibleAssets': 0, 'AssetsNonCurrent': 384921, 'AssetsCurrent': 228326, 'PropertyPlantAndEquipment': 0, 'remainder_Assets': 103885}} |
Graph
Absolute values for 0001443863, Biocorrx Inc
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 0 |
| 1 | AssetsNonCurrent | 489,536 |
| 2 | AssetsCurrent | 974,925 |
| 3 | PropertyPlantAndEquipment | 128,605 |
| 4 | remainder_Assets | 233,934 |
| 5 | LongTermLiabilities | 0 |
| 6 | LiabilitiesCurrent | 3,052,374 |
| 7 | remainder_Liabilities | 2,984,979 |
| 8 | LaborExpense | 0 |
| 9 | CostOfGoodsAndServicesSold | 95,948 |
| 10 | GeneralAndAdministrativeExpense | 3,167,577 |
| 11 | GoodwillImpairmentLoss | 0 |
| 12 | OperatingCostsAndExpenses | 0 |
| 13 | DepreciationDepletionAndAmortization | 77,254 |
| 14 | SellingAndMarketingExpense | 0 |
| 15 | ResearchAndDevelopmentExpense | 4,273,815 |
| 16 | remainder_Expenses | 0 |
| 17 | remainder_Revenues | 122,621 |
| 18 | remainder_NetIncome | 3,985,466 |
| 19 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,827,000 |
| 1 | Liabilities | 6,037,353 |
| 2 | Expenses | 7,614,594 |
| 3 | Revenues | 122,621 |
| 4 | StockholdersEquity | -4,210,353 |
| 5 | NetIncome | -3,506,507 |
| 6 | ComprehensiveNetIncome | -3,506,507 |
| 7 | BaseVar | 9,793,517 |
| 8 | EconomicCapitalRatio | -3.87 |